< Back to previous page
CEO research orientation, organizational context, and innovation in the pharmaceutical industry
Journal Contribution - Journal Article
This study develops and tests a comprehensive framework that explains what, when, and how CEO characteristics influence firms' innovation outcomes in R&D-intensive industries. Empirical evidence from 109 CEOs from 87 U.S.-based pharmaceutical firms over the period 2001-2013 reveals that research-oriented CEOs - those with ability and motivation for science and technology - increase their firms' innovation outcomes. The results indicate that the CEO-innovation relationship strongly depends on the extent of CEOs' managerial discretion, which is shaped by the organizational context. We contribute to a more comprehensive understanding of the role of CEOs in firms ' innovation performance differentials.
Journal: R & D management
Pages: 239 - 254
Keywords:A1 Journal article
Authors from:Higher Education